Genetics of Immune-Mediated Glomerular Diseases: Focus on Complement.

Area of Science:

• Nephrology
• Immunology
• Genetics

Background:

• Immune-mediated glomerular diseases encompass a broad spectrum, from rare genetic disorders to common multifactorial conditions.
• Immune-mediated glomerular injury involves complex interactions between innate and adaptive immune systems.
• Significant research over two decades has focused on elucidating the genetic underpinnings of these diseases.

Purpose of the Study:

• To investigate the role of genetic factors, particularly complement system abnormalities, in immune-mediated glomerular diseases.
• To understand the impact of complement gene variations on the pathogenesis of both rare and common kidney diseases.
• To explore the balance between protective and detrimental functions of the complement system in kidney health.

Main Methods:

• Genetic analysis of patients with atypical hemolytic uremic syndrome (aHUS) and membranoproliferative glomerulonephritis (MPGN).
• Identification of gene abnormalities encoding proteins in the alternative complement pathway.
• Comparative analysis of complement dysregulation mechanisms in different glomerular diseases.

Main Results:

• Complement gene abnormalities identified in over 50% of aHUS patients and approximately 20% of MPGN patients.
• aHUS-associated abnormalities primarily cause cell-surface complement dysregulation.
• Fluid-phase complement activation is prevalent in genetic MPGN cases.
• Findings stimulate research into complement's role in IgA nephropathy and lupus nephritis.

Conclusions:

• The alternative complement pathway plays a critical role in the pathogenesis of immune-mediated glomerular diseases like aHUS and MPGN.
• Genetic variations in complement genes contribute to disease susceptibility and progression.
• Understanding complement system dynamics is crucial for managing a range of kidney diseases, including multifactorial ones.